Home > Press > BioForce Nanosciences Receives Second Half of a $400,000 NIH Grant
BioForce Nanosciences, Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc. (OTCBB:BFNH), announced today the receipt of the second year of funding under a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant for nearly $200,000, furthering its Emerging Technologies program. This brings the total funding under the grant to $400,000. The funding will be used to construct and evaluate a nanobiosensor capable of detecting protein biomarkers from just a few cells. The proposed nanobiosensor, with the tradename Chip-on-a-Tip(TM), opens the door to fast and informative analysis of minute protein samples such as those studied in forensics or biopsy microsamples.
BioForce Nanosciences Receives Second Half of a $400,000 NIH Grant
AMES, IA | Posted on July 27th, 2007
This SBIR Phase I grant work will progress through April 2008 and involve a feasibility study to construct and evaluate the Chip-on-a-Tip(TM) device. If successful, this device is anticipated to provide the means for early detection of cancer and other diseases with a significant reduction in patient discomfort.
Dr. Eric Henderson, BioForce's founder and CEO commented, "This concept creates a test so small that it can be brought directly to the sample origin, for example a cell, eliminating the difficulties associated with transporting extremely small quantities of sample extracts to a remote test site. The technology has the capacity to allow individuals to carry out personalized medicine at home." The research is made possible by BioForce's Nano eNabler(TM) benchtop molecular printer, which is capable of "printing" the extremely small tests on the nanobiosensor.
Dr. Saju Nettikadan, director of Emerging Technologies at BioForce said, "The NIH funding validates BioForce's belief that miniaturization of biological tests is a pathway to minimally invasive molecular diagnostics. BioForce's Chip-on-a-Tip(TM) project is just one element of our Emerging Technologies division."
About BioForce Nanosciences, Inc.
BioForce Nanosciences develops and commercializes nanotech tools and solutions for the life sciences. For more information, visit http://www.bioforcenano.com .
This news release contains forward-looking information that may be affected by certain risks and uncertainties, including those risks and uncertainties described in the Company's most recent filings with the Securities and Exchange Commission. The Company's actual results could differ materially from such forward-looking statements. We assume no duty to update these statements at any future date.
For more information, please click here
RedChip Companies Inc.
Robert Rehse, 1-800-REDCHIP (733-2447) ext 111
BioForce Nanosciences, Inc.
Deb Happe, 515-233-8333, Ext. 123
Director of Communications
Copyright © Business Wire 2007
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Copper shines as flexible conductor August 29th, 2014
Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices August 28th, 2014
RMIT delivers $30m boost to micro and nano-tech August 26th, 2014
Symphony of nanoplasmonic and optical resonators leads to magnificent laser-like light emission August 26th, 2014
Raman Whispering Gallery Detects Nanoparticles September 1st, 2014
Nanoscale assembly line August 29th, 2014
New analytical technology reveals 'nanomechanical' surface traits August 29th, 2014
New Vice President Takes Helm at CNSE CMOST: Catherine Gilbert To Lead CNSE Children’s Museum of Science and Technology Through Expansion And Relocation August 29th, 2014
Rice physicist emerges as leader in quantum materials research: Nevidomskyy wins both NSF CAREER Award and Cottrell Scholar Award August 20th, 2014
Oxford Instruments Asylum Research Receives the 2014 Microscopy Today Innovation Award for blueDrive Photothermal Excitation August 18th, 2014
AQUANOVA receives Technology Leadership Award 2014 FROST & SULLIVAN honors NovaSOL® Technology again August 12th, 2014
Focal blood-brain-barrier disruption with high-frequency pulsed electric fields August 12th, 2014